Viewing Study NCT00765856


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2026-05-23 @ 10:05 AM
Study NCT ID: NCT00765856
Status: TERMINATED
Last Update Posted: 2020-12-16
First Post: 2008-10-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Sponsor: Endo Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Opioid tolerant View
None Pediatric View
None Male 6-17 years of age View
None Female 6-17 years of age View
None Pain View
None Non malignant View
None Malignant View